Lin, et al., 'Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids', Diabetes Obes
In the expert opinion section, the author suggests that once-daily oral semaglutide might not replace the once-weekly subcutaneous semaglutide in treating type 2 diabetes
Ozempic is the brand name for semaglutide, a prescription drug that helps regulate blood sugar and support weight loss
Prediction 1: More Lawsuits Due to Adverse Effects Back in March 2024, USA Today reported: More than five dozen lawsuits accuse Novo Nordisk or Eli Lilly of failing to notify patients about the side effects of their popular diabetes or weight-loss drugs. As of the first of this month 16 months later that number has jumped to 1,997 pending lawsuits against Wegovy and other GLP-1 drugs
Weeks 17-20 may increase to 12.5mg weekly
GIP Pathway (Glucose-Dependent Insulinotropic Polypeptide) Improves insulin sensitivity and may promote more favorable fat distribution